This was recorded from a live webinar dated September 7, 2021. If you claimed credit for the live session you should not claim credit for this module.

Faculty

Needs Statement

Addressing end-of-life issues and the provision of Hospice care has been shown to provide numerous benefits to patients and their families including but not limited to: pain and symptom management, quality of life for the patient, medical care consistent with a patient’s goals, preferences and values, caregiver well-being. Irrespective of hospice referral, understanding the changing roles of care providers at end-of-life and palliative efforts designed to promote quality rather than quantity of life remains a challenge for most. Formal training in end-of-life issues and palliative/hospice care in dementia does not exist to any substantive degree in the majority of healthcare professional training programs.

Target Audience

This is for ALL Certified Nursing Facilities personnel in Kentucky.

Objectives

Upon completion of this educational activity, participants will be able to:
1. Describe appropriate identification of conditions that warrant transition to palliative/hospice care models in residents of long term care facilities.
2. Discuss palliative/hospice care strategies to improve quality of life & reduce caregiver burden in the end stage of life in patients with and without appreciable dementia.

Accreditation

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME
This enduring material is designated for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

IPE Competencies

• Values/Ethics for Interprofessional Practice
• Roles/ Responsibilities

Other
UK Healthcare CECentral certifies this activity for 1.50 hours of participation.

ASWB ACE
As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course. Social workers completing this course receive 1.50 clinical continuing education credits.

CNE
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.50 nursing contact hours.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

Gregory Jicha, MD, faculty for this activity has received study activity payment for contract research from AbbView, BioHaven, Eisai, and Novartis.

All of the relevant financial relationships listed for this individual have been mitigated. No other speakers, planners, or content reviewers have any relevant financial relationships to disclose.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Acknowledgment

The KEEN-CDC Initiative is funded through CMS Grant #2018-04-KY- 0329 and the Kentucky Office of the Inspector General.